These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 9233633

  • 21. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 22. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C, Troye-Blomberg M, Deloron P, Kabilan L, Lepers JP, Savel J, Perlmann P.
    J Immunol; 1991 Oct 01; 147(7):2295-301. PubMed ID: 1717554
    [Abstract] [Full Text] [Related]

  • 23. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H.
    Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134
    [Abstract] [Full Text] [Related]

  • 24. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
    Sinigaglia F, Guttinger M, Kilgus J, Doran DM, Matile H, Etlinger H, Trzeciak A, Gillessen D, Pink JR.
    Nature; 2007 Jul 09; 336(6201):778-80. PubMed ID: 2462673
    [Abstract] [Full Text] [Related]

  • 25. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
    Togna AR, Del Giudice G, Verdini AS, Bonelli F, Pessi A, Engers HD, Corradin G.
    J Immunol; 1986 Nov 01; 137(9):2956-60. PubMed ID: 2428881
    [Abstract] [Full Text] [Related]

  • 26. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.
    Nardin EH, Oliveira GA, Calvo-Calle JM, Castro ZR, Nussenzweig RS, Schmeckpeper B, Hall BF, Diggs C, Bodison S, Edelman R.
    J Infect Dis; 2000 Nov 01; 182(5):1486-96. PubMed ID: 11023472
    [Abstract] [Full Text] [Related]

  • 27. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM, de Oliveira GA, Clavijo P, Maracic M, Tam JP, Lu YA, Nardin EH, Nussenzweig RS, Cochrane AH.
    J Immunol; 1993 Feb 15; 150(4):1403-12. PubMed ID: 7679427
    [Abstract] [Full Text] [Related]

  • 28. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF, Branigan J, Smith G, Houghten RA.
    Pept Res; 1990 Feb 15; 3(3):110-5. PubMed ID: 1724615
    [Abstract] [Full Text] [Related]

  • 29. T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee.
    Nardin E, Clavijo P, Mons B, van Belkum A, Ponnudurai T, Nussenzweig RS.
    J Immunol; 1991 Mar 01; 146(5):1674-8. PubMed ID: 1704402
    [Abstract] [Full Text] [Related]

  • 30. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH, Calvo-Calle JM, Oliveira GA, Nussenzweig RS, Schneider M, Tiercy JM, Loutan L, Hochstrasser D, Rose K.
    J Immunol; 2001 Jan 01; 166(1):481-9. PubMed ID: 11123327
    [Abstract] [Full Text] [Related]

  • 31. MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide.
    Prato S, Maxwell T, Pinzón-Charry A, Schmidt CW, Corradin G, López JA.
    Eur J Immunol; 2005 Mar 01; 35(3):681-9. PubMed ID: 15688345
    [Abstract] [Full Text] [Related]

  • 32. Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge.
    Schwenk R, Lumsden JM, Rein LE, Juompan L, Kester KE, Heppner DG, Krzych U.
    Vaccine; 2011 Nov 08; 29(48):8847-54. PubMed ID: 21983360
    [Abstract] [Full Text] [Related]

  • 33. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 34. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
    Nardin EH, Nussenzweig RS, Altszuler R, Herrington D, Levine M, Murphy J, Davis J, Bathurst I, Barr P, Romero P.
    Bull World Health Organ; 1990 Nov 01; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
    [Abstract] [Full Text] [Related]

  • 35. Inducing a cell-mediated immune response against peptides of the Plasmodium vivax circumsporozoite protein.
    Thomas BE, Sridevi K, Chopra N, Haq W, Rao DN.
    Ann Trop Med Parasitol; 2001 Sep 01; 95(6):573-86. PubMed ID: 11672463
    [Abstract] [Full Text] [Related]

  • 36. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M, Li S, Murata K, Rodriguez D, Rodriguez JR, Bacik I, Bennink JR, Yewdell JW, Garcia-Sastre A, Nussenzweig RS.
    J Immunol; 1994 Nov 15; 153(10):4636-48. PubMed ID: 7525709
    [Abstract] [Full Text] [Related]

  • 37. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 38. Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens.
    Londoño JA, Gras-Masse H, Dubeaux C, Tartar A, Druilhe P.
    J Immunol; 1990 Sep 01; 145(5):1557-63. PubMed ID: 2143519
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.